A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3667

NCT04097938 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: GLPG3667 oral suspension
DRUG: Placebos
DRUG: GLPG3667 capsules

Sponsor

Lakefront Biotherapeutics NV